메뉴 건너뛰기




Volumn 27, Issue 11, 2009, Pages 1742-1743

The case against heavy PETing

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

EID: 64649088021     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.20.1665     Document Type: Editorial
Times cited : (42)

References (14)
  • 1
    • 32044438650 scopus 로고    scopus 로고
    • Positron emission tomography (PET) in post-therapy assessment of cancer
    • Juweid M, Cheson BD: Positron emission tomography (PET) in post-therapy assessment of cancer. N Engl J Med 354:496-507, 2006
    • (2006) N Engl J Med , vol.354 , pp. 496-507
    • Juweid, M.1    Cheson, B.D.2
  • 2
    • 36348942458 scopus 로고    scopus 로고
    • The role of FDG-PET scans in patients with lymphoma
    • Seam P, Juweid ME, Cheson BD: The role of FDG-PET scans in patients with lymphoma. Blood 110:3507-3516, 2007
    • (2007) Blood , vol.110 , pp. 3507-3516
    • Seam, P.1    Juweid, M.E.2    Cheson, B.D.3
  • 3
    • 23744498053 scopus 로고    scopus 로고
    • 18F]fluoro-2-deoxy-D- glucose positron emission tomography (FDG-PET) in aggressive lymphoma: An early prognostic tool for predicting patient outcome
    • 18F]fluoro-2-deoxy-D- glucose positron emission tomography (FDG-PET) in aggressive lymphoma: An early prognostic tool for predicting patient outcome. Blood 106:1376-1381, 2005
    • (2005) Blood , vol.106 , pp. 1376-1381
    • Haioun, C.1    Itti, E.2    Rahmouni, A.3
  • 4
    • 34548486030 scopus 로고    scopus 로고
    • 18F]fluoro-2-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: A report from a joint Italian-Danish study
    • 18F]fluoro-2-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: A report from a joint Italian-Danish study. J Clin Oncol 25:3746-3752, 2007
    • (2007) J Clin Oncol , vol.25 , pp. 3746-3752
    • Gallamini, A.1    Hutchings, M.2    Rigacci, L.3
  • 5
    • 23044478389 scopus 로고    scopus 로고
    • Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: Prevalence and scan interpretation
    • Castellucci P, Nanni C, Farsad M, et al: Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: Prevalence and scan interpretation. Nucl Med Commun 26:689-694, 2005
    • (2005) Nucl Med Commun , vol.26 , pp. 689-694
    • Castellucci, P.1    Nanni, C.2    Farsad, M.3
  • 6
    • 33947512956 scopus 로고    scopus 로고
    • Use of positron emission tomography for response assessment of lymphoma: Consensus recommendations of the Imaging Subcommittee of the International Harmonization Project in Lymphoma
    • Juweid ME, Stroobants S, Hoekstra OS, et al: Use of positron emission tomography for response assessment of lymphoma: Consensus recommendations of the Imaging Subcommittee of the International Harmonization Project in Lymphoma. J Clin Oncol 25:571-578, 2007
    • (2007) J Clin Oncol , vol.25 , pp. 571-578
    • Juweid, M.E.1    Stroobants, S.2    Hoekstra, O.S.3
  • 7
    • 33947496614 scopus 로고    scopus 로고
    • Revised response criteria for malignant lymphoma
    • Cheson BD, Pfistner B, Juweid ME, et al: Revised response criteria for malignant lymphoma. J Clin Oncol 25:579-586, 2007
    • (2007) J Clin Oncol , vol.25 , pp. 579-586
    • Cheson, B.D.1    Pfistner, B.2    Juweid, M.E.3
  • 8
    • 64649086758 scopus 로고    scopus 로고
    • 18F] fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma
    • 18F] fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma. J Clin Oncol 27:1781-1787, 2009
    • (2009) J Clin Oncol , vol.27 , pp. 1781-1787
    • Zinzani, P.L.1    Stefoni, V.2    Tani, M.3
  • 9
    • 0025736610 scopus 로고
    • Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission
    • Weeks JC, Yeap BY, Canellos GP, et al: Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission. J Clin Oncol 9:1196-1203, 1991
    • (1991) J Clin Oncol , vol.9 , pp. 1196-1203
    • Weeks, J.C.1    Yeap, B.Y.2    Canellos, G.P.3
  • 10
    • 0032926756 scopus 로고    scopus 로고
    • Stages I-III follicular lymphoma: Role of CT of the abdomen and pelvis in follow-up studies
    • Oh YK, Ha CS, Samuels BI, et al: Stages I-III follicular lymphoma: Role of CT of the abdomen and pelvis in follow-up studies. Radiology 210:483-486, 1999
    • (1999) Radiology , vol.210 , pp. 483-486
    • Oh, Y.K.1    Ha, C.S.2    Samuels, B.I.3
  • 11
    • 34748849175 scopus 로고    scopus 로고
    • Who actually detects relapse in Hodgkin lymphoma: Patient or physician
    • abstr 3124
    • Foltz LM, Song KW, Connors JM: Who actually detects relapse in Hodgkin lymphoma: Patient or physician. Blood 104:853a-854a, 2004 (abstr 3124)
    • (2004) Blood , vol.104
    • Foltz, L.M.1    Song, K.W.2    Connors, J.M.3
  • 12
    • 33646860107 scopus 로고    scopus 로고
    • Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: A retrospective analysis of a uniformly-treated patient population
    • Liedtke M, Hamlin PA, Moskowitz CH, et al: Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: A retrospective analysis of a uniformly-treated patient population. Ann Oncol 17:909-913, 2006
    • (2006) Ann Oncol , vol.17 , pp. 909-913
    • Liedtke, M.1    Hamlin, P.A.2    Moskowitz, C.H.3
  • 13
    • 34548805294 scopus 로고    scopus 로고
    • Phase II trial of dose-dense R-CHOP followed by risk-adapted consolidation with either ICE or ICE and ASCT, based upon the results of biopsy confirmed abnormal interim restaging PET scan, improves outcome in patients with advanced stage DLBCL
    • abstr 532
    • Moskowitz C, Hamlin PA, Horwitz SM, et al: Phase II trial of dose-dense R-CHOP followed by risk-adapted consolidation with either ICE or ICE and ASCT, based upon the results of biopsy confirmed abnormal interim restaging PET scan, improves outcome in patients with advanced stage DLBCL. Blood 108:161a, 2006 (abstr 532)
    • (2006) Blood , vol.108
    • Moskowitz, C.1    Hamlin, P.A.2    Horwitz, S.M.3
  • 14
    • 64649093421 scopus 로고    scopus 로고
    • Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: A systematic review
    • Terasawa T, Lau J, Bardet S, et al: Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: A systematic review. J Clin Oncol 27:1906-1914, 2009
    • (2009) J Clin Oncol , vol.27 , pp. 1906-1914
    • Terasawa, T.1    Lau, J.2    Bardet, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.